CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Revenues:
Revenue, net	$ 13,586	$ 18,341	$ 21,033	$ 31,463
Costs and expenses:
Cost of revenues	11,084	9,800	19,694	17,160
Selling, general and administrative expenses	4,989	5,187	11,706	10,700
Impairment charges	0	0	8,373	0
Product development and research expenses	1,880	2,668	3,680	5,657
Total costs and expenses	17,953	17,655	43,453	33,517
Operating income/(loss)	(4,367)	686	(22,420)	(2,054)
Other Expense:
Foreign currency exchange gain/(loss)	2,125	553	528	(291)
Debt partial extinguishment of 2019 Notes	0	0	0	(185)
Interest and other expense, net	(7,520)	(5,155)	(13,396)	(10,102)
Change in the fair value of derivative liabilities	(4,591)	0	(5,849)	0
Loss before income tax (benefit)/expense	(14,353)	(3,916)	(41,137)	(12,632)
Income tax (benefit)/ expense	(21)	73	31	81
Net loss attributable to common shareholders	$ (14,332)	$ (3,989)	$ (41,168)	$ (12,713)
Basic and diluted loss per share (in dollars per share)	$ (2.56)	$ (0.74)	$ (7.50)	$ (2.36)
Weighted average shares of common stock outstanding:
Basic and diluted shares (in shares)	5,593,557	5,384,909	5,491,554	5,382,764